Legal & General Group PLC Crispr Therapeutics Ag Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Legal & General Group PLC holds 102,588 shares of CRSP stock, worth $4.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102,588
Previous 82,910 23.73%
Holding current value
$4.85 Million
Previous $5.65 Million 1.96%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$51.17 - $68.18 $1.01 Million - $1.34 Million
19,678 Added 23.73%
102,588 $5.54 Million
Q1 2024

May 14, 2024
BUY
$60.67 - $89.12 $961,437 - $1.41 Million
15,847 Added 23.63%
82,910 $5.65 Million
Q4 2023

Feb 15, 2024
SELL
$38.62 - $72.18 $3,359 - $6,279
-87 Reduced 0.13%
67,063 $4.2 Million
Q3 2023

Nov 14, 2023
BUY
$45.39 - $59.0 $123,233 - $160,185
2,715 Added 4.21%
67,150 $3.05 Million
Q2 2023

Aug 14, 2023
BUY
$43.47 - $67.77 $145,233 - $226,419
3,341 Added 5.47%
64,435 $3.62 Million
Q1 2023

May 15, 2023
BUY
$41.0 - $56.12 $247,599 - $338,908
6,039 Added 10.97%
61,094 $2.76 Million
Q4 2022

Feb 14, 2023
BUY
$39.19 - $65.67 $24,258 - $40,649
619 Added 1.14%
55,055 $2.24 Million
Q3 2022

Nov 14, 2022
SELL
$61.1 - $83.78 $53,157 - $72,888
-870 Reduced 1.57%
54,436 $3.56 Million
Q2 2022

Aug 22, 2022
BUY
$43.23 - $73.83 $113,651 - $194,099
2,629 Added 4.99%
55,306 $3.36 Million
Q1 2022

May 16, 2022
BUY
$53.19 - $79.24 $35,903 - $53,487
675 Added 1.3%
52,677 $3.31 Million
Q4 2021

Feb 14, 2022
BUY
$70.09 - $111.29 $302,157 - $479,771
4,311 Added 9.04%
52,002 $3.94 Million
Q3 2021

Nov 15, 2021
BUY
$110.2 - $156.64 $1.31 Million - $1.87 Million
11,926 Added 33.35%
47,691 $5.34 Million
Q2 2021

Aug 12, 2021
BUY
$100.84 - $161.89 $255,125 - $409,581
2,530 Added 7.61%
35,765 $5.79 Million
Q1 2021

May 17, 2021
BUY
$110.72 - $210.04 $426,714 - $809,494
3,854 Added 13.12%
33,235 $4.05 Million
Q4 2020

Feb 12, 2021
SELL
$79.67 - $173.23 $97,038 - $210,994
-1,218 Reduced 3.98%
29,381 $4.5 Million
Q3 2020

Nov 13, 2020
BUY
$78.5 - $100.64 $331,348 - $424,801
4,221 Added 16.0%
30,599 $2.56 Million
Q2 2020

Aug 14, 2020
BUY
$38.5 - $76.05 $666,088 - $1.32 Million
17,301 Added 190.6%
26,378 $1.94 Million
Q1 2020

May 14, 2020
SELL
$33.68 - $62.53 $833,681 - $1.55 Million
-24,753 Reduced 73.17%
9,077 $428,000
Q4 2019

Feb 13, 2020
BUY
$36.68 - $73.13 $1.2 Million - $2.39 Million
32,745 Added 3017.97%
33,830 $2.06 Million
Q2 2019

Aug 14, 2019
BUY
$35.45 - $48.2 $19,320 - $26,269
545 Added 100.93%
1,085 $51,000
Q4 2018

Feb 15, 2019
BUY
$22.73 - $42.34 $7,932 - $14,776
349 Added 182.72%
540 $15,000
Q2 2018

Aug 10, 2018
BUY
$42.62 - $73.59 $8,140 - $14,055
191 New
191 $11,000

Others Institutions Holding CRSP

# of Institutions
523
Shares Held
58M
Call Options Held
1.73M
Put Options Held
1.84M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.69B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email